ArticleScientific reports2024
Synthesis of eco-friendly lipid-magnetite nanocomposite encapsulated Poinciana extract as promising insecticide against Culex pipiens.
Article in Scientific reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Chitosan-coated lipid nanocarriers co-delivering curcumin and α-terpinene with enhanced larvicidal activity against Cx. pipiens via oxidative stress.Scientific reports · 2026Article
- Photocatalytic degradation of polyethylene films using green-synthesized ZnO and FeScientific reports · 2026Article
- Nanoencapsulation enhances stability, release behavior, and antimicrobial properties of Sage and Thyme essential oils.Scientific reports · 2025Article
- Toxicity of Foeniculum vulgare essential oil, its main component and nanoformulation against Phthorimaea absoluta and the generalist predator Macrolophus pygmaeus.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mosquito-borne diseases represent a growing health challenge over time. Nanostructured lipid carriers (NLCs) are the second generation of solid lipid nanoparticles (SLNs), and they continue to attract significant interest as potential diagnostic and therapeutic tools in disease inhibition and insect control. Activated ingredients presented in the Poinciana leaves were extracted and GC-MS data indicated an increased abundance of terpenes, flavonoids, and phenolic substances. Poinciana extract was encapsulated to the vicinity of nanostructure lipid carrier, Po-NLC, and surface modified with magnetic nanoparticles, Po-NLC-MNPs. The synthesized nanoparticles depicted average particle size of 73.2 and 75.55 nm while zeta potential of (- 29.4) and (‒ 4.44 mV) for Po-NLC and Po-NLC-MNPs, respectively. Transmission electron microscope and morphology determination showed regular, irregular spherical and oval shapes with diverse single particle size. X-rays diffraction pattern of the freely synthesized MNPs was compared to the decorated NLC and the results manifested that the NLC was successfully decorated with MNPs. The larvicidal activity of plant extract, Poinciana extract (Po), and their nanoparticle conjugates against 3rd instar larvae of Culex pipiens was evaluated at 50, 100, 200, 500, 1000, and 1500 ppm concentrations. Both high and low concentrations of Po-NLC-MNPs, indicated potential larval mortality than plant extracts (Po extract) itself. The mortality rate reached 100% for 3rd instar larvae. Based on their relative toxicity, (Po-NLC-MNPs) was the best at killing larvae, followed by Po-NLC. The synthesized nps were checked for their cytotoxic effect against wi38 cell line. The in-vitro cytotoxicity results indicated that there was no significant cytotoxicity and the nanocomposite barely caused weak changes in the tested cells. The synthesized nanoparticles have potential to create a new generation of eco-friendly, effective alternatives for controlling mosquito-borne diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.